Zerigo Health’s US Food and Drug Administration-cleared, handheld NB-UVB light device is paired with a smartphone app care providers to enable patients to self-administer clinical light therapy from home.  

Lisa Rometty is the new Chief Executive Officer at Zerigo Health.

Ms. Rometty joins Zerigo after serving as President of CVS Kidney Care. Previously, she served as President of Global Client Solutions at Syneos Health.

"Lisa's go-to-market experience and success building home health ecosystems for consumers living with chronic conditions will be instrumental in scaling Zerigo," says Glen Tullman, Executive Chairman of Zerigo Health, Chief Executive Officer of Transcarent, and Managing Partner at 7wireVentures, in a news release. "The market is searching for cost-effective alternatives to expensive biologics, and we are excited to have Lisa driving our mission to empower people living with chronic skin conditions with convenient, affordable, and personalized care."

Zerigo Health’s US Food and Drug Administration-cleared, handheld NB-UVB light device is paired with a smartphone app care providers to enable patients to self-administer clinical light therapy from home.  

"I am excited to join the Zerigo Health team at such an important time in the company's development. People living with chronic skin conditions deserve to have more convenient and effective treatment options that give them the freedom to get back to life," adds Ms. Rometty.  "We have a significant opportunity to make the home the preferred site of care for consumers and to create outsized value throughout the healthcare ecosystem."